(Q44607749)

4 December 2017

title

Intensive induction chemotherapy and delayed irradiation in the management of parameningeal rhabdomyosarcoma (English)

1 reference

4 December 2017

Intensive Induction Chemotherapy and Delayed Irradiation in the Management of Parameningeal Rhabdomyosarcoma (English)

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

18 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

18 March 2024

4

Douglas S Hawkins

1 reference

4 December 2017

Judy Felgenhauer

3

1 reference

4 December 2017

Stephen C. Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528099

18 March 2024

Skyler K. Lindsley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528099

18 March 2024

James G. Douglas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528099

18 March 2024

language of work or name

1 reference

1 October 2003

1 reference

full work available at URL

4 December 2017

https://journals.lww.com/00043426-200310000-00006

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Journal of Pediatric Hematology/Oncology

18 March 2024

published in

1 reference

4 December 2017

volume

25

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

774-779

1 reference

4 December 2017

1

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

The Intergroup Rhabdomyosarcoma Study-I. A final report

18 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

The Intergroup Rhabdomyosarcoma Study-II.

18 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

The Third Intergroup Rhabdomyosarcoma Study

18 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease

18 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: a report from the International Rhabdomyosarcoma Workshop

18 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: a report of the Intergroup Rhabdomyosarcoma Study (IRS)

18 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study

18 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.

18 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Rhabdomyosarcoma of Parameningeal Sites

18 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Medical and Pediatric Oncology

18 March 2024

12

35

218

Wharam

2001

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

18 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas

18 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children

18 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas

18 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Nonparametric Estimation from Incomplete Observations

18 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Role of radiation therapy in parameningeal rhabdomyosarcoma

18 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Parameningeal rhabdomyosarcoma: results of an international workshop

18 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the

18 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases

18 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Phase II evaluation of adriamycin in human neoplasia

18 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

18 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. A Pediatric Oncology Group Phase II study

18 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma

18 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study

18 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

Three dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas

18 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00043426-200310000-00006

18 March 2024

Identifiers

1 reference

4 December 2017

1 reference